OSM-DAN LTD
- Country
- Israel
- Type
- Beneficiary
- Grants received
- 16
Funding record
- 16 grants on record
- €4,002,993.75 awarded in total
- 2008–2021 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
4 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- BAR ILAN UNIVERSITY
- UNIVERSITAT POLITECNICA DE CATALUNYA
- PROJECT SAS DI MASSIMO PERUCCA
- WEIZMANN INSTITUTE OF SCIENCE
- ASCEND TECHNOLOGIES LIMITED
- CENTITVC - CENTRO DE NANOTECNOLOGIAE MATERIAIS TECNICOS FUNCIONAIS EINTELIGENTES
- FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
- ACCIONA CONSTRUCCION SA
Calls from this organisation
No published calls from this organisation.
Grants received
- An Open Innovation Test Bed for Nano-Enabled Bio-Based PUR Foams and Composites
- Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma.
- Novel Products for Construction and Automotive Industries Based on Bio Materials and Natural Fibres
- Pre-commercial lines for production of surface nanostructured antimicrobial and anti-biofilm textiles, medical devices and water treatment membranes
- Functional materials for fast diagnosis of wound infection
- Develop and demonstrate a ‘Mini-factory’ concept for production of personalized skin care products for elderly population
- Novel Composite Oxides by Combinatorial Material Synthesis for Next Generation All-Oxide-Photovoltaics
- Novel approaches for prevention and degeneration of pathogenic bacteria biofilms formed on medical devices e.g. catheters
- Gaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities
- In-line characterisation of nanoparticles using a combination of analytical techniques in real time
- A Modular Nanosystems Platform for Advanced Cancer Management: Nano-vehicles; Tumor Targeting and Penetration Agents; Molecular Imaging, Degradome based Therapy
- Paving the Way for Future Emerging DNA-based Technologies: Computer-Aided Design and Manufacturing of DNA libraries
- Biomimetic nano-fiber-based nucleus pulposus regeneration for the treatment of degenerative disc disease
- A pilot line of antibacterial and antifungal medical textiles based on a sonochemical process
- Recombination: an old and new tool for plant breeding
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.